SPRY4 and hepatocellular carcinoma: When HCC patients were tested against healthy controls, the AUC was 0.796 (0.734-0.858) for HULC, 0.768 (0.706-0.830) for MALAT1, 0.895 (0.854-0.936) for Linc00152, 0.602 (0.526-0.678) for PTENP1, 0.785 (0.723-0.847) for PTTG3P, 0.808 (0.750-0.866) for SPRY4-IT1, 0.812 (0.754-0.870) for UBE2CP3, 0.858 (0.810-0.907) for UCA1, and 0.862 (0.815-0.909) for AFP, respectively (Figure 3(a) and Table 6).